Skip to content

Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511435-10-00
Acronym
CT‑01-CD-1
Enrollment
154
Registered
2024-12-16
Start date
2025-04-30
Completion date
Unknown
Last updated
2026-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

None listed

Sponsors

Captor Therapeutics S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

France, Germany, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026